278 related articles for article (PubMed ID: 30226542)
1. lncRNA LINC01296 regulates the proliferation, metastasis and cell cycle of osteosarcoma through cyclin D1.
Yu X; Pang L; Yang T; Liu P
Oncol Rep; 2018 Nov; 40(5):2507-2514. PubMed ID: 30226542
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of long intergenic noncoding RNA 01296 in ovarian cancer impacts invasion, apoptosis and cell cycle distribution via regulating EMT.
Xu H; Zheng JF; Hou CZ; Li Y; Liu PS
Cell Signal; 2019 Oct; 62():109341. PubMed ID: 31176022
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of the oncogene lncRNA NEAT1 restores the availability of
Hu Y; Yang Q; Wang L; Wang S; Sun F; Xu D; Jiang J
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654165
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195.
Zhou Q; Chen F; Zhao J; Li B; Liang Y; Pan W; Zhang S; Wang X; Zheng D
Oncotarget; 2016 Dec; 7(50):82620-82633. PubMed ID: 27813492
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis.
Wang X; Hu K; Chao Y; Wang L
Biomed Pharmacother; 2019 Jun; 114():108798. PubMed ID: 30909141
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of the long non-coding RNA TUG1 is associated with cell proliferation, migration, and invasion in breast cancer.
Fan S; Yang Z; Ke Z; Huang K; Liu N; Fang X; Wang K
Biomed Pharmacother; 2017 Nov; 95():1636-1643. PubMed ID: 28950664
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
Yuan Q; Yu H; Chen J; Song X; Sun L
Exp Cell Res; 2018 Jan; 362(1):209-216. PubMed ID: 29155364
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of LncRNA-RP11-317J10.2 promotes cell proliferation and invasion and predicts poor prognosis in colorectal cancer.
Luo J; Xu LN; Zhang SJ; Jiang YG; Zhuo DX; Wu LH; Jiang X; Huang Y
Scand J Gastroenterol; 2018 Jan; 53(1):38-45. PubMed ID: 29073791
[TBL] [Abstract][Full Text] [Related]
10. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
Yuan Q; Zhang Y; Feng L; Jiang Y
J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
[TBL] [Abstract][Full Text] [Related]
11. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis.
Zhang R; Xia T
Int J Oncol; 2017 Nov; 51(5):1460-1470. PubMed ID: 29048648
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression.
Zhao D; Wang S; Chu X; Han D
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1342-1348. PubMed ID: 30966832
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA LINC01296 is associated with poor prognosis in ESCC and promotes ESCC cell proliferation, migration and invasion.
Wang B; Liang T; Li J
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4524-4531. PubMed ID: 30058683
[TBL] [Abstract][Full Text] [Related]
15. LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21.
Liu W
Cancer Biother Radiopharm; 2019 May; 34(4):258-263. PubMed ID: 31070482
[No Abstract] [Full Text] [Related]
16. Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.
Duan G; Zhang C; Xu C; Xu C; Zhang L; Zhang Y
Int J Oncol; 2019 Jan; 54(1):17-28. PubMed ID: 30365098
[TBL] [Abstract][Full Text] [Related]
17. LncRNA WWOX‑AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells.
Qu G; Ma Z; Tong W; Yang J
Mol Med Rep; 2018 Jul; 18(1):779-788. PubMed ID: 29845204
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating Notch2 by sponging miR-195-5p.
Zhou S; Yu L; Xiong M; Dai G
Biochem Biophys Res Commun; 2018 Jan; 495(2):1822-1832. PubMed ID: 29229388
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma.
Qu Y; Zheng S; Kang M; Dong R; Zhou H; Zhao D; Zhao J
Biomed Pharmacother; 2018 Feb; 98():899-906. PubMed ID: 29571260
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma.
Zhang B; Li YL; Zhao JL; Zhen O; Yu C; Yang BH; Yu XR
Biomed Pharmacother; 2018 Sep; 105():1-9. PubMed ID: 29807229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]